China Focus: New policies set to ease burden for China's cancer patients

      Source: Xinhua| 2018-04-14 17:08:53|Editor: Yurou
      Video PlayerClose

      BEIJING, April 14 (Xinhua) -- A series of new policies on anticancer drugs in China will give hope to the country's cancer patients.

      According to the statement released after an executive meeting of the State Council on Thursday, from May 1, import tariffs on all common drugs including cancer drugs, cancer alkaloid-based drugs, and imported traditional Chinese medicine will be exempted.

      Also, value added tax in the production and import of drugs will drop by a large margin, which experts believe will be more effective in easing the economic burden of patients.

      With various measures taken into consideration, it is estimated that the policies will lower the drug prices by at least 20 percent, said Shi Luwen, director of the international research center on medicine management at Peking University.

      The measures will significantly enhance the availability and inclusiveness of the drugs, reduce the burden of patients' families, and will help prevent poverty caused by illness, he said.

      Statistics indicate that many cancer patients in China have been struggling to acquire cheap, quality medicine.

      According to the national cancer institute, the market for antineoplastic drugs in China exceeds 120 billion yuan (about 19.1 billion U.S. dollars). However, they are usually too expensive for working class families.

      "We are speeding up in making high-quality generic drugs available in the market, but most of the targeted anticancer drugs were still imported," said Liu Lihong, a doctor at the Beijing Chaoyang Hospital.

      Chen Wenming, another doctor at the hospital, said that despite social insurance, patients in Beijing still have to pay 20 percent of the total price of the drugs. The percentage is even higher in less developed areas.

      For this, the State Council put forward a solution at the meeting, asking for the timely inclusion of imported new drugs in the range of medical insurance, especially urgent cancer drugs.

      In addition, the import procedures of new medicine will be streamlined, as importing enterprises will take charge of the examination of the drugs, instead of compulsory examination by authorities.

      "It will make it easier for patients to access the drugs in terms of timing," said Shi Luwen. "It also adds to the enterprises' responsibilities to ensure the quality and safety of the drugs, while saving their time."

      As for the long term, experts are expecting higher capabilities of medical institutions on the grassroots level, and the balance of the share of drugs in different areas, so that urgent medicine including anticancer drugs can more efficiently and accurately benefit the people.

      "More measures will soon be implemented to make sure those in urgent need of medicine can get sufficient, quality and cheaper drugs in time," the National Health Commission said.

      TOP STORIES
      EDITOR’S CHOICE
      MOST VIEWED
      EXPLORE XINHUANET
      010020070750000000000000011100001371109981
      主站蜘蛛池模板: 亚洲综合一区二区| 国产对白受不了了中文对白| 久久久久国产精品免费网站| 欧美浓毛大泬视频| 啊啊啊好爽在线观看| 欧美丰满白嫩bbwbbw| 天天av天天翘天天综合网| 久久久久久夜精品精品免费啦| 欧美激情视频一区二区| 加勒比综合在线| 高中生被老师第一次处破女| 国产美女mm131爽爽爽毛片| 三年片在线观看免费观看大全中国| 日韩黄色片网站| 亚洲欧美日本另类| 粗大的内捧猛烈进出视频| 国产三香港三韩国三级不卡| 伊人影视在线观看日韩区| 天天摸天天看天天做天天爽| 丰满熟妇乱又伦| 最近中文字幕网2019| 亚洲福利视频一区二区三区| 精品午夜福利1000在线观看| 国产乱码一区二区三区爽爽爽| va天堂va亚洲va影视中文字幕| 在线观看污污视频| 三上悠亚在线观看免费| 日本免费新一区二区三区| 亚洲中文字幕无码久久2020 | 亚洲H在线播放在线观看H| 波多野结衣痴女系列88| 午夜a成v人电影| 被公侵幕岬奈奈美中文字幕| 国产日产精品_国产精品毛片| 8天堂资源在线| 天堂а√在线官网| 一区二区日韩欧美| 拍拍拍无挡视频免费观看1000 | 国产在线一区观看| 色综合天天综合中文网| 国产精品高清一区二区三区|